Cargando…
Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020
Preexposure prophylaxis (PrEP) with antiretroviral medication has been proven effective in reducing the risk for acquiring human immunodeficiency virus (HIV). The fixed-dose combination tablet of tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) was approved by the U.S. Food and Drug Administr...
Autores principales: | Tanner, Mary R., Miele, Peter, Carter, Wendy, Valentine, Sheila Salvant, Dunville, Richard, Kapogiannis, Bill G., Smith, Dawn K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188407/ https://www.ncbi.nlm.nih.gov/pubmed/32324724 http://dx.doi.org/10.15585/mmwr.rr6903a1 |
Ejemplares similares
-
Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016) -
Consensus Guidelines for Pediatric Intensive Care Units in India, 2020
por: Khilnani, Praveen, et al.
Publicado: (2020) -
Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022) -
Indian Academy of Pediatrics Consensus Guidelines for Adolescent Friendly Health Services
por: Galagali, Preeti M., et al.
Publicado: (2022) -
Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2020–21) and Update on Immunization for Children Aged 0 Through 18 Years
por: Kasi, Srinivas G., et al.
Publicado: (2020)